Sunmax Biotechnology Co., Ltd. (TPEX: 4728)
273.00
-5.00 (-1.80%)
Sep 10, 2024, 11:11 AM CST
Sunmax Biotechnology Revenue
Sunmax Biotechnology had revenue of 453.67M TWD in the quarter ending June 30, 2024, with 8.68% growth. This brings the company's revenue in the last twelve months to 1.76B, up 12.53% year-over-year. In the year 2023, Sunmax Biotechnology had annual revenue of 1.69B with 20.64% growth.
Revenue (ttm)
1.76B
Revenue Growth
+12.53%
P/S Ratio
8.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.69B | 288.91M | 20.64% |
Dec 31, 2022 | 1.40B | 364.41M | 35.19% |
Dec 31, 2021 | 1.04B | 179.81M | 21.01% |
Dec 31, 2020 | 855.85M | 261.71M | 44.05% |
Dec 31, 2019 | 594.15M | 290.08M | 95.40% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition